Educating Patients on IOL Options Is Key
-
By
-
Allison Young, MD
-
Jana Waters, MD
-
April 1, 2025
-
10 min
By
Allison Young, MD
Jana Waters, MD
April 1, 2025
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026